|
ATE218541T1
(de)
|
1992-08-25 |
2002-06-15 |
Searle & Co |
Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
|
|
US6221578B1
(en)
|
1996-01-26 |
2001-04-24 |
Virco N.V. |
Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains
|
|
US6242187B1
(en)
|
1996-01-29 |
2001-06-05 |
Virologic, Inc. |
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
|
|
AU8897698A
(en)
*
|
1997-07-30 |
1999-02-22 |
Virologic, Inc. |
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
|
|
WO1999051776A1
(en)
*
|
1998-04-07 |
1999-10-14 |
Southern Research Institute |
High-throughput method for screening for antiviral activity
|
|
US7037644B1
(en)
|
1998-05-26 |
2006-05-02 |
Virologic, Inc. |
Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
|
|
CN1532290A
(zh)
*
|
1998-05-26 |
2004-09-29 |
病毒科学公司 |
监控非核苷类逆转录酶抑制剂抗逆转录病毒治疗的途径与方法
|
|
US20030148307A1
(en)
|
1998-06-19 |
2003-08-07 |
Department Of Health & Human Services, C/O Centers Of Disease Control And Prevention |
Method and kit for detecting resistance to antiviral drugs
|
|
DE69924118T2
(de)
*
|
1998-06-19 |
2005-12-22 |
The Government of the United States of America, as represented by the Secretary Centers for Disease and Prevention, Office of Technology |
Verfahren und reagentiensatz zur erkennung von antiviralen wirkstoff resistenzen
|
|
US6787126B1
(en)
|
1998-06-19 |
2004-09-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method and kit for detecting resistance to antiviral drugs
|
|
BR9912209A
(pt)
*
|
1998-06-24 |
2002-11-05 |
Virologic Inc |
Recursos e métodos para monitoração de terapia anti-retroviral inibidora de transcriptase reversa de nucleosìdeo e guia de decisões terapêuticas no tratamento de hiv/aids
|
|
MXPA01012270A
(es)
|
1999-05-28 |
2003-06-24 |
Virco Nv |
Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
|
|
EP1326640A4
(en)
*
|
2000-09-15 |
2004-12-15 |
Virologic Inc |
NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
|
|
WO2002033402A2
(en)
*
|
2000-10-20 |
2002-04-25 |
Virco Bvba |
Establishment of biological cut-off values for predicting resistance to therapy
|
|
EP1356082A2
(en)
|
2000-10-20 |
2003-10-29 |
Virco Bvba |
Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
|
|
US7247439B1
(en)
|
2001-06-04 |
2007-07-24 |
Monogram Biosciences, Inc. |
Method of evaluating a patient antibody response to envelope proteins of a virus
|
|
US7097970B2
(en)
|
2001-06-04 |
2006-08-29 |
Monogram Biosciences, Inc. |
Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
|
|
WO2003040390A2
(en)
|
2001-11-08 |
2003-05-15 |
Tibotec Pharmaceuticals Ltd. |
Protease assay for therapeutic drug monitoring
|
|
US7217506B2
(en)
|
2002-07-01 |
2007-05-15 |
Tibotec Pharmaceuticals, Ltd. |
Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance
|
|
AU2003251732B2
(en)
|
2002-07-01 |
2008-09-18 |
Tibotec Pharmaceuticals Ltd. |
New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
|
|
DE20218008U1
(de)
|
2002-11-21 |
2003-03-06 |
FESTO AG & Co., 73734 Esslingen |
Anordnung von mehreren Handhabungsvorrichtungen
|
|
US8603736B2
(en)
|
2004-06-07 |
2013-12-10 |
Monogram Biosciences, Inc. |
Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
|
|
US8178291B2
(en)
|
2005-02-18 |
2012-05-15 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
|
|
CA2601922C
(en)
|
2005-02-18 |
2020-11-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
|
|
EP2458018A3
(en)
|
2005-05-27 |
2012-07-25 |
Monogram BioSciences, Inc. |
Methods and compositions for determining resistance of HIV-1 to protease inhibitors
|
|
WO2006133267A2
(en)
|
2005-06-06 |
2006-12-14 |
Monogram Biosciences, Inc. |
Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs
|
|
US9506121B2
(en)
|
2005-06-06 |
2016-11-29 |
Monogram Biosciences, Inc. |
Methods for determining resistance or susceptibility to HIV entry inhibitors
|
|
WO2007146336A2
(en)
|
2006-06-13 |
2007-12-21 |
Monogram Biosciences, Inc. |
Molecular determinants associated with enhanced ability to enter cells expressing cxcr4
|
|
US8338101B2
(en)
*
|
2007-01-23 |
2012-12-25 |
Virco Bvba |
Method for designing a drug regime for HIV-infected patients
|
|
WO2008106115A2
(en)
|
2007-02-26 |
2008-09-04 |
Monogram Biosciences, Inc. |
Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
|
|
US20190183855A1
(en)
*
|
2016-08-10 |
2019-06-20 |
Riken |
Composition for treating hepatitis b, and method for evaluating replication activity of hepatitis b virus
|
|
RU2646472C1
(ru)
*
|
2016-10-07 |
2018-03-05 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации |
Способ оценки эффективности терапии инфекции вызванной вирусом герпеса человека 6 типа у детей
|
|
US10793876B2
(en)
*
|
2016-12-29 |
2020-10-06 |
Virongy L.L.C. |
Retro- and lenti-HBV hybrid vectors and constructs
|
|
CN109722465B
(zh)
*
|
2019-01-07 |
2022-02-01 |
福建省疾病预防控制中心(福建省健康教育促进中心、福建省卫生检验检测中心) |
一种hiv耐药检测载体和构建方法
|
|
JP7773731B2
(ja)
*
|
2020-06-24 |
2025-11-20 |
シァメン・ユニヴァーシティ |
薬物スクリーニングモデル及びＨＢＶ ｃｃｃＤＮＡを標的化する方法
|